Get an alert when GW PHARMACEUTICALS LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-09-30 (in 4mo)

Last filed for 2024-12-31

Confirmation statement due

2027-03-01 (in 10mo)

Last made up 2026-02-15

Watchouts

None on the register

Name history

Renamed 3 times since incorporation

  1. GW PHARMACEUTICALS LIMITED 2021-06-04 → present
  2. GW PHARMACEUTICALS PLC 2001-06-01 → 2021-06-04
  3. GW PHARMACEUTICALS GROUP PLC 2001-03-06 → 2001-06-01
  4. MAWLAW 541 PLC 2001-02-15 → 2001-03-06

Accounts

Audit & accounting basis

Accounting basis
FRS 101
Reporting scope
Standalone (parent only)
Auditor
KPMG
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“The Directors having made enquiries believe that the Company has adequate resources to continue in operational existence for a period of 12 months from the date of approval and that it is appropriate to continue to adopt the going concern basis in preparing the financial statements.”

Group structure

  1. GW PHARMACEUTICALS LIMITED · parent
    1. Jazz Pharmaceuticals Operations UK Limited 100% · Production and commercial
    2. Jazz Pharmaceuticals Research UK Ltd 100% · Research and development
    3. Jazz Financing UK Limited 100% · Commercial
    4. GW UK Services Ltd 100% · Commercial
    5. GWP Trustee Company Ltd 100% · Dissolved
    6. Jazz Pharmaceuticals Japan K.K 100% · Commercial

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

3 active · 33 resigned

Name Role Appointed Born Nationality
PATEL, Alkesh Secretary 2024-04-03
FLANAGAN, Amanda Director 2025-02-10 Aug 1971 Irish
SPACKMAN, David James Director 2023-01-13 Jan 1976 British
Show 33 resigned officers
Name Role Appointed Resigned
DOODY, Aislinn Jane Secretary 2023-01-13 2024-04-03
GEORGE, Adam David Secretary 2008-03-05 2020-12-18
HILLHOUSE, Robert James Secretary 2001-02-15 2001-05-31
LAUGHTON, Jonathan Michael Secretary 2001-05-31 2008-03-05
SNYDER, Douglas Secretary 2020-12-18 2021-08-12
WARD, Iain Secretary 2021-08-12 2023-01-13
ARMISSOGLIO ÉP. LEPELLETIER, Nelly Alexandra Director 2023-01-13 2025-02-10
BROWN, Cabot Director 2013-02-19 2021-05-05
BROWN, Cabot Director 2013-01-18 2013-01-18
CAMPBELL, Adrian Director 2021-05-05 2023-01-01
FORREST, Richard George Director 2007-03-15 2013-01-18
GANGOLLI, Julian Steatham Director 2015-07-16 2017-02-13
GEORGE, Adam David Director 2012-06-01 2017-02-13
GOVER, Justin David Director 2001-03-05 2021-05-05
GRYSKA, David Director 2020-09-09 2021-05-05
GUY, Geoffrey William, Dr Director 2001-03-05 2021-05-05
KIRK, David Francis Director 2001-09-10 2012-06-01
LAUGHTON, Jonathan Michael Director 2001-03-05 2001-09-10
LYNCH, Thomas Gerard Director 2010-07-27 2020-04-01
MACE, David Champion Director 2001-03-05 2007-03-20
MACKEY, Catherine Director 2017-12-21 2021-05-05
MORRISON, David John Director 2006-02-09 2007-03-15
MOUNTFORD, Peter Director 2001-03-05 2006-02-09
NOBLE, James Julian Director 2007-01-26 2021-05-05
SCHRAM, Hans Director 2003-04-16 2010-07-27
SECOR, Alicia Mary Director 2017-12-21 2021-05-05
TOVEY, Christopher John Director 2012-10-01 2017-02-13
WALDEGRAVE, William Arthur, Lord Director 2017-12-21 2021-05-05
WARD, Iain Stuart Director 2021-05-05 2023-01-13
WHITTLE, Brian Anthony Director 2001-03-05 2008-03-18
WRIGHT, Stephen, Dr Director 2005-03-22 2017-02-13
MAWLAW ADMINISTRATION LIMITED Corporate Director 2001-02-15 2001-03-05
MAWLAW CORPORATE SERVICES LIMITED Corporate Director 2001-02-15 2001-03-05

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Jazz Pharmaceuticals Uk Holdings Limited Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2021-05-05 Active

Filing timeline

Last 20 of 404 total filings

Date Type Category Description
2026-02-17 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-09-30 AA accounts Accounts with accounts type full
2025-02-18 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-02-12 AP01 officers Appoint person director company with name date PDF
2025-02-10 TM01 officers Termination director company with name termination date PDF
2024-11-27 MR01 mortgage Mortgage create with deed with charge number charge creation date PDF
2024-10-12 AA accounts Accounts with accounts type full
2024-04-18 AP03 officers Appoint person secretary company with name date PDF
2024-04-18 TM02 officers Termination secretary company with name termination date PDF
2024-02-19 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-01-23 MR01 mortgage Mortgage create with deed with charge number charge creation date PDF
2023-10-26 AA accounts Accounts with accounts type full
2023-02-20 CS01 confirmation-statement Confirmation statement with updates PDF
2023-02-06 PSC05 persons-with-significant-control Change to a person with significant control
2023-02-06 PSC02 persons-with-significant-control Notification of a person with significant control
2023-02-06 PSC09 persons-with-significant-control Withdrawal of a person with significant control statement
2023-01-16 AP01 officers Appoint person director company with name date PDF
2023-01-16 AP01 officers Appoint person director company with name date PDF
2023-01-13 AP03 officers Appoint person secretary company with name date PDF
2023-01-13 TM01 officers Termination director company with name termination date PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
2

last 12 months

Capital events
0

last 24 months

Officers appointed
0

last 12 months

Officers resigned
0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

Latest filed period vs the prior one

Accounts are PDF-filed; numeric extraction for this statement type (this accounts) is not yet supported in StatDesk. See the Companies House filing for the underlying figures.

Official Companies House page